awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24634360-1B723B2A-B040-4BD1-BCE0-90382F4D6C16
Q24634360-1B723B2A-B040-4BD1-BCE0-90382F4D6C16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24634360-1B723B2A-B040-4BD1-BCE0-90382F4D6C16
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia
P2860
Q24634360-1B723B2A-B040-4BD1-BCE0-90382F4D6C16
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24634360-1B723B2A-B040-4BD1-BCE0-90382F4D6C16
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
466141b0c3855e20f619dc26951b257eab326d28
P2860
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells